Starting this Friday, North China’s Shanxi Province removed its previous ban on the over-the-counter sale of antipyretic drugs, which was a policy during the coronavirus epidemic control period. 

(File photo: CFP)

For all drug companies including wholesalers and retailers, the previous management and control of antipyretic drugs, such as iboprofin and aspirin, is over, according to the notice issued by Shanxi Medical Products Administration.

(Compiled by Ma Xiaoxi)